P

Inventor

MCKERRECHER DARREN

GB19 patents
⚠️ This page may combine multiple inventors who share the name “MCKERRECHER DARREN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ASTRAZENECA AB

16 patents
US7842694B2Nov 30, 2010

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

ASTRAZENECA AB11 citations92
US7642259B2Jan 5, 2010

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

ASTRAZENECA AB18 citations92
US7642263B2Jan 5, 2010

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

ASTRAZENECA AB16 citations92
US7524957B2Apr 28, 2009

Compounds effecting glucokinase

ASTRAZENECA AB31 citations91
US7390908B2Jun 24, 2008

Compounds effecting glucokinase

ASTRAZENECA AB33 citations91
US7074800B1Jul 11, 2006

Quinazoline derivatives as angiogenesis inhibitors

ASTRAZENECA AB37 citations90
US7745475B2Jun 29, 2010

Heteroaryl benzamide derivatives as GLK activators

ASTRAZENECA AB14 citations83
US8030340B2Oct 4, 2011

Indazolyl sulphonamide derivatives useful as glucocorticoid modulators

ASTRAZENECA AB8 citations82
US7728030B2Jun 1, 2010

Chemical compounds 572

ASTRAZENECA AB9 citations82
US7671060B2Mar 2, 2010

Heteroaryl benzamide derivatives

ASTRAZENECA AB13 citations81
US7709505B2May 4, 2010

Benzofuran derivatives, process for their preparation and intermediates thereof

ASTRAZENECA AB4 citations59
US7977328B2Jul 12, 2011

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

ASTRAZENECA AB0 citations51
US7951830B2May 31, 2011

Compounds effecting glucokinase

ASTRAZENECA AB1 citations51
US7964725B2Jun 21, 2011

Heteroarylbenzamide derivatives for use in the treatment of diabetes

ASTRAZENECA AB0 citations49
US7943607B2May 17, 2011

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

ASTRAZENECA AB0 citations41
US7498335B2Mar 3, 2009

Method of producing an antiangiogenic or vascular permeability reducing effect

ASTRAZENECA AB0 citations39

STOKES ELAINE S E

1 patent

ASTRAZENECA UK LTD

1 patent

BERGER MARKUS

1 patent